These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

226 related items for PubMed ID: 16474854

  • 1. Rituximab.
    Doan T, Massarotti E.
    Drugs Today (Barc); 2005 Dec; 41(12):785-97. PubMed ID: 16474854
    [Abstract] [Full Text] [Related]

  • 2. Anti B cell therapy (rituximab) in the treatment of autoimmune diseases.
    Kazkaz H, Isenberg D.
    Curr Opin Pharmacol; 2004 Aug; 4(4):398-402. PubMed ID: 15251135
    [Abstract] [Full Text] [Related]

  • 3. B cell depletion in autoimmune disease.
    Gorman C, Leandro M, Isenberg D.
    Arthritis Res Ther; 2003 Aug; 5 Suppl 4(Suppl 4):S17-21. PubMed ID: 15180893
    [Abstract] [Full Text] [Related]

  • 4. [Treatment of systemic autoimmune and inflammatory diseases with rituximab].
    Bussone G, Hachulla E, Sibilia J, Michel M, Godeau B, Guillevin L, Mouthon L.
    Presse Med; 2009 May; 38(5):808-23. PubMed ID: 19297127
    [Abstract] [Full Text] [Related]

  • 5. B cells as a therapeutic target in autoimmune diseases other than rheumatoid arthritis.
    Looney RJ.
    Rheumatology (Oxford); 2005 May; 44 Suppl 2():ii13-ii17. PubMed ID: 15851522
    [Abstract] [Full Text] [Related]

  • 6. Rituximab: expanding role in therapy for lymphomas and autoimmune diseases.
    Rastetter W, Molina A, White CA.
    Annu Rev Med; 2004 May; 55():477-503. PubMed ID: 14746532
    [Abstract] [Full Text] [Related]

  • 7. [Rituximab and autoimmune disorders therapy].
    Quint L.
    Rev Med Interne; 2004 Oct; 25(10):752-4. PubMed ID: 15471601
    [Abstract] [Full Text] [Related]

  • 8. Anti-B cell therapy (rituximab) in the treatment of autoimmune diseases.
    Chambers SA, Isenberg D.
    Lupus; 2005 Oct; 14(3):210-4. PubMed ID: 15807198
    [Abstract] [Full Text] [Related]

  • 9. Rituximab: a B-cell depletion therapy for dermatologic disease.
    Prajapati V, Mydlarski PR.
    Skin Therapy Lett; 2007 Oct; 12(6):6-9. PubMed ID: 17762903
    [Abstract] [Full Text] [Related]

  • 10. [B cell targeting therapy using the anti-CD20 antibody in autoimmune diseases].
    Tanaka Y.
    Yakugaku Zasshi; 2009 Jun; 129(6):675-9. PubMed ID: 19483410
    [Abstract] [Full Text] [Related]

  • 11. A review of the current use of rituximab in autoimmune diseases.
    Gürcan HM, Keskin DB, Stern JN, Nitzberg MA, Shekhani H, Ahmed AR.
    Int Immunopharmacol; 2009 Jan; 9(1):10-25. PubMed ID: 19000786
    [Abstract] [Full Text] [Related]

  • 12. Anti-CD20 therapy and autoimmune disease: therapeutic opportunities and evolving insights.
    Silverman GJ.
    Front Biosci; 2007 Jan 01; 12():2194-206. PubMed ID: 17127456
    [Abstract] [Full Text] [Related]

  • 13. What is the role of maintenance rituximab in follicular NHL?
    Maloney DG.
    Oncology (Williston Park); 2008 Jan 01; 22(1):20-6; discussion 26, 29, 33-4. PubMed ID: 18251281
    [Abstract] [Full Text] [Related]

  • 14. Rituximab in refractory autoimmune diseases: Brazilian experience with 29 patients (2002-2004).
    Scheinberg M, Hamerschlak N, Kutner JM, Ribeiro AA, Ferreira E, Goldenberg J, Kiss MH, Chahade WH.
    Clin Exp Rheumatol; 2006 Jan 01; 24(1):65-9. PubMed ID: 16539821
    [Abstract] [Full Text] [Related]

  • 15. Successful treatment of primary cardiac lymphoma with monoclonal CD20 antibody (rituximab).
    Nakagawa Y, Ikeda U, Hirose M, Ubukata S, Katsuki TA, Kaminishi Y, Saito T, Hironaka M, Izumi T, Shimada K.
    Circ J; 2004 Feb 01; 68(2):172-3. PubMed ID: 14745155
    [Abstract] [Full Text] [Related]

  • 16. [Clinical observation of Rituximab in a CD20+B non-Hodgkin's lymphoma].
    Hao LC, Zhang LZ.
    Zhonghua Er Ke Za Zhi; 2003 Aug 01; 41(8):627. PubMed ID: 14744396
    [No Abstract] [Full Text] [Related]

  • 17. Rituximab anti-CD20 monoclonal antibody therapy in non-Hodgkin's lymphoma: safety and efficacy of re-treatment.
    Davis TA, Grillo-López AJ, White CA, McLaughlin P, Czuczman MS, Link BK, Maloney DG, Weaver RL, Rosenberg J, Levy R.
    J Clin Oncol; 2000 Sep 01; 18(17):3135-43. PubMed ID: 10963642
    [Abstract] [Full Text] [Related]

  • 18. Acute tumor lysis syndrome induced by rituximab in diffuse large B-cell lymphoma.
    Jabr FI.
    Int J Hematol; 2005 Nov 01; 82(4):312-4. PubMed ID: 16298821
    [Abstract] [Full Text] [Related]

  • 19. Rituximab in treatment-resistant autoimmune blistering skin disorders.
    Schmidt E, Bröcker EB, Goebeler M.
    Clin Rev Allergy Immunol; 2008 Feb 01; 34(1):56-64. PubMed ID: 18270859
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.